http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2059520-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b6fc801b5bfe5304ffa40d938db6e09 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B26-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09B26-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-38 |
| filingDate | 1970-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1971-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2059520-A1 |
| titleOfInvention | Azine anti-tumour agent |
| abstract | Azines of formula: (where R is (2-methyl)allyl) are prepd. by heating: with HOCH2CO2H or HO-CH(CH3)-CO2H with. |
| priorityDate | 1969-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.